Sabra Health Care REIT Inc (SBRA) Expected to Post Quarterly Sales of $145.59 Million

Share on StockTwits

Analysts expect Sabra Health Care REIT Inc (NASDAQ:SBRA) to report sales of $145.59 million for the current quarter, Zacks reports. Four analysts have made estimates for Sabra Health Care REIT’s earnings, with the highest sales estimate coming in at $154.03 million and the lowest estimate coming in at $139.82 million. Sabra Health Care REIT posted sales of $166.47 million in the same quarter last year, which would indicate a negative year-over-year growth rate of 12.5%. The business is scheduled to issue its next quarterly earnings results after the market closes on Sunday, February 24th.

According to Zacks, analysts expect that Sabra Health Care REIT will report full-year sales of $630.09 million for the current fiscal year, with estimates ranging from $624.02 million to $639.46 million. For the next financial year, analysts anticipate that the business will post sales of $596.94 million, with estimates ranging from $566.08 million to $659.19 million. Zacks’ sales calculations are an average based on a survey of sell-side research firms that cover Sabra Health Care REIT.

Several research analysts have recently issued reports on SBRA shares. Mizuho cut Sabra Health Care REIT from a “buy” rating to a “neutral” rating and set a $21.00 price objective for the company. in a research report on Tuesday, November 13th. Zacks Investment Research raised Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Wednesday, October 31st. BMO Capital Markets reaffirmed a “hold” rating and set a $17.00 price objective on shares of Sabra Health Care REIT in a research report on Monday, January 14th. SunTrust Banks cut Sabra Health Care REIT from a “buy” rating to a “hold” rating in a research report on Tuesday, December 18th. Finally, BidaskClub raised Sabra Health Care REIT from a “sell” rating to a “hold” rating in a research report on Tuesday, January 29th. Two equities research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have given a buy rating to the stock. Sabra Health Care REIT presently has a consensus rating of “Hold” and a consensus price target of $21.36.

Shares of NASDAQ:SBRA traded down $0.05 on Wednesday, hitting $20.51. 1,479,100 shares of the company’s stock were exchanged, compared to its average volume of 1,637,679. The stock has a market cap of $3.70 billion, a P/E ratio of 8.46, a P/E/G ratio of 2.47 and a beta of 1.02. Sabra Health Care REIT has a 1-year low of $15.70 and a 1-year high of $23.83. The company has a debt-to-equity ratio of 1.00, a quick ratio of 2.88 and a current ratio of 2.88.

The company also recently announced a quarterly dividend, which will be paid on Thursday, February 28th. Investors of record on Friday, February 15th will be given a $0.45 dividend. The ex-dividend date of this dividend is Thursday, February 14th. This represents a $1.80 dividend on an annualized basis and a dividend yield of 8.78%. Sabra Health Care REIT’s dividend payout ratio (DPR) is presently 74.07%.

Several hedge funds and other institutional investors have recently made changes to their positions in SBRA. Advisors Asset Management Inc. boosted its position in shares of Sabra Health Care REIT by 136.0% in the 2nd quarter. Advisors Asset Management Inc. now owns 59,512 shares of the real estate investment trust’s stock valued at $431,000 after purchasing an additional 34,290 shares during the period. Jane Street Group LLC purchased a new stake in Sabra Health Care REIT during the 2nd quarter valued at approximately $276,000. Bank of New York Mellon Corp raised its stake in Sabra Health Care REIT by 0.5% during the 2nd quarter. Bank of New York Mellon Corp now owns 2,663,709 shares of the real estate investment trust’s stock valued at $57,881,000 after acquiring an additional 12,607 shares during the last quarter. NEXT Financial Group Inc purchased a new stake in Sabra Health Care REIT during the 3rd quarter valued at approximately $132,000. Finally, Sumitomo Mitsui Asset Management Company LTD purchased a new stake in Sabra Health Care REIT during the 3rd quarter valued at approximately $3,922,000. 92.52% of the stock is owned by hedge funds and other institutional investors.

About Sabra Health Care REIT

As of September 30, 2018, Sabra's investment portfolio included 487 real estate properties held for investment (consisting of (i) 350 Skilled Nursing/Transitional Care facilities, (ii) 91 Senior Housing communities (?Senior Housing – Leased?), (iii) 24 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan, (iv) one pre-development loan and (v) 17 other loans), 11 preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

See Also: Convertible Shares

Get a free copy of the Zacks research report on Sabra Health Care REIT (SBRA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Sabra Health Care REIT Inc  Expected to Post Quarterly Sales of $145.59 Million
Sabra Health Care REIT Inc Expected to Post Quarterly Sales of $145.59 Million
RingCentral  Issues Q1 2019 Earnings Guidance
RingCentral Issues Q1 2019 Earnings Guidance
$0.49 EPS Expected for Wolverine World Wide, Inc.  This Quarter
$0.49 EPS Expected for Wolverine World Wide, Inc. This Quarter
Traders Sell SPDR S&P 500 ETF Trust  on Strength
Traders Sell SPDR S&P 500 ETF Trust on Strength
Investors Buy Citigroup  on Weakness
Investors Buy Citigroup on Weakness
Alexander’s  vs. Regency Centers  Critical Comparison
Alexander’s vs. Regency Centers Critical Comparison


Leave a Reply

 
© 2006-2019 Zolmax.